Decreased serum phosphate levels are a useful biomarker to predict occurrence and severity of cytokine release syndrome in chimeric antigen receptor T‐cell therapy

Saved in:

Bibliographic Details
Published in	British journal of haematology Vol. 200; no. 1; pp. e1 - e3
Main Authors	Nakamura, Naokazu, Arai, Yasuyuki, Kitawaki, Toshio, Jo, Tomoyasu, Mizumoto, Chisaki, Kanda, Junya, Nishikori, Momoko, Yamashita, Kouhei, Takaori‐Kondo, Akifumi
Format	Journal Article
Language	English
Published	England Blackwell Publishing Ltd 01.01.2023 John Wiley and Sons Inc
Subjects	Biomarkers Cell therapy Cell- and Tissue-Based Therapy chimeric antigen receptor T cell (CAR‐T) Chimeric antigen receptors cytokine release syndrome (CRS) Cytokine Release Syndrome - etiology Cytokines Hematology Humans hypophosphataemia Immunotherapy, Adoptive - adverse effects Letter to the Editor Letters to the Editor–Online Only Phosphates predictive marker Receptors, Antigen, T-Cell - genetics Receptors, Chimeric Antigen hypophosphataemia cytokine release syndrome (CRS) predictive marker chimeric antigen receptor T cell (CAR-T)
Online Access	Get full text
ISSN	0007-1048 1365-2141 1365-2141
DOI	10.1111/bjh.18504

More Information
Bibliography:	SourceType-Scholarly Journals-1 content type line 14 ObjectType-Editorial-2 ObjectType-Commentary-1 ObjectType-Article-2 ObjectType-Correspondence-1 content type line 23
ISSN:	0007-1048 1365-2141 1365-2141
DOI:	10.1111/bjh.18504